-
Some Cures, Some Lingering Ailments
The Drugs & Cosmetics Bill gets it right on regulation of medical devices but continues with drug inspection regime that lacks transparency.
2026-07-08 -
Supreme Court Settles the Law on the Interplay Between the IBC and the Limitation Act
This article discusses the issue of application of Section 14 of the Limitation Act to applications under Section 7 of the IBC.
2026-07-08 -
Towards a Sustainable Green Bonds Market in India: A Review of the Green Bonds Framework in India
The author notes the general improvement in awareness about green investing and examines the green bonds framework in India.
2026-07-08 -
Analyzing the RBI FLDG Guidelines
This article first describes what an FLDG arrangement is and then analyzes the guidelines on the same.
2026-07-08 -
Unguarded Secrets: The Case for a Dedicated Trade Secret Statute in India
There is a reasonable argument that India's courts have managed trade secret disputes adequately without a dedicated statute. However, "adequate" protection for well-resourced parties with carefully drafted NDAs is not the same as a reliable legal framework. MSMEs without the resources for patent registration, startups whose entire commercial value rests on a single process, and inventors without a contractual relationship with the party who misappropriates their idea are left exposed.
2026-07-08 -
Group of Companies Doctrine: Evasive Piercing and a Conglomerate's Lament
This article intends to analyze how the reasoning that the doctrine operates independent of corporate law is at best evasive.
2026-07-08